An open-label study of patients with major depressive disorder reported reductions in glutamate and N-Acetylaspartate concentrations in the anterior cingulate cortex, as measured by Magnetic Resonance Spectroscopy (MRS), following psilocybin treatment.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (4)

• psilocybin concept
• Major Depressive Disorder concept
• anterior cingulate cortex concept
• glutamate concept